Teva, Mylan Get FDA OK For Zyprexa Generic
The U.S. Food & Drug Administration gave the approval to Israel-based Teva Pharmaceutical Industries on Monday and to Pennsylvania-based Mylan Laboratories Inc. on Tuesday.
If a judge finds in favor of generics makers in their patent litigation with Lilly, they could begin to sell generic versions of Zyprexa immediately. However, an appeal...
To view the full article, register now.